Amphastar Pharmaceuticals, Inc. Quarterly Interest Expense in USD from Q2 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2013 to Q1 2024.
  • Amphastar Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $8.61M, a 2064% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $35.4M, a 1772% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Interest Expense for 2023 was $27.2M, a 1371% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Interest Expense for 2022 was $1.85M, a 109% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Interest Expense for 2021 was $885K, a 137% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $35.4M $8.61M +$8.21M +2064% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $27.2M $9.46M +$8.93M +1691% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $18.2M $13.7M +$13.1M +2321% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $5.09M $3.6M +$3.21M +807% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.89M $398K +$43K +12.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $1.85M $528K +$360K +214% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.49M $566K +$39K +7.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $1.45M $397K +$311K +362% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.14M $355K +$251K +241% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $885K $168K +$80K +90.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $805K $527K +$352K +201% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $453K $86K +$51K +146% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $402K $104K +$28K +36.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $374K $88K +$45K +105% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $329K $175K +$153K +695% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $176K $35K +$11K +45.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $165K $76K +$46K +153% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $119K $43K +$42K +4200% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $77K $22K -$102K -82.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $179K $24K -$76K -76% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $255K $30K +$12K +66.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $243K $1K -$133K -99.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $376K $124K -$140K -53% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $516K $100K -$137K -57.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $653K $18K -$173K -90.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $826K $134K +$80K +148% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 $746K $264K -$17K -6.05% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $763K $237K -$68K -22.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $831K $191K -$193K -50.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $1.02M $54K -$150K -73.5% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $1.17M $281K +$49K +21.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.13M $305K +$95K +45.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $1.03M $384K +$43K +12.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $987K $204K +$755K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 $232K $232K -$272K -54% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $504K $210K -$266K -55.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $770K $341K +$161K +89.4% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $609K -$551K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 $504K +$309K +158% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 $476K +$239K +101% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $180K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $195K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $237K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.